Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 05, 2019

SELL
$48.23 - $66.16 $500,096 - $686,013
-10,369 Closed
0 $0
Q4 2017

Jan 24, 2018

SELL
$37.77 - $47.75 $99,826 - $126,203
-2,643 Reduced 20.31%
10,369 $482,000
Q3 2017

Oct 06, 2017

BUY
$34.14 - $40.45 $444,229 - $526,335
13,012
13,012 $526,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $561M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Woodstock Corp Portfolio

Follow Woodstock Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

News

Stay updated on Woodstock Corp with notifications on news.